The Hospital Universitario de Fuenlabrada is seeking suppliers for the provision of a specific radiopharmaceutical, Lutathera® (with active ingredient [177-LU]-DOTA0-TYR3-OCTREOTATO), in a concentration of 370 MBq/mL for infusion. This contract is valued at approximately €279,936 and is part of the
Contract awarded. Originally published 10 months ago.
No single supplier dominates the field.
In healthcare medical, PUBLIC ENTITY UNIVERSITY HOSPITAL OF FUENLABRA has awarded 5 contracts to 5 suppliers.
Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, URTICA SP Z OO — the field to beat, or your route in as a partner.
This contract involves the supply of exclusive Cyramza medications from Lilly for the Fuenlabrada University Hospital. The total value of the contract is €106,375. Suppliers are invited to provide these specific medications, which are essential for patient care in the health sector. The awarded supp
The Hospital Universitario de Fuenlabrada is seeking suppliers for laboratory materials, including reagents, controls, calibrators, and specific consumables. Additionally, suppliers must provide the necessary equipment for conducting autoimmunity determinations in the hospital's laboratory. This con
The Hospital Universitario de Fuenlabrada is seeking suppliers for the provision of implantable, radiopaque artificial urinary sphincters specifically designed for male patients. This contract is valued at €170,000 and is part of the health sector. The awarded supplier for this contract is Productos
UK Home Office seeks a global tuberculosis screening service provider to manage visa applicant testing across international locations through various delivery models.
Norfolk County Council is seeking a contractor to provide technology-enabled and virtual care services that help residents maintain independence and improve outcomes while remaining in their own homes.
Market engagement RFI for integrated criminal justice liaison, prison reentry and mental health treatment services across Lancashire and Cumbria, closing 4 September 2026.
UKHSA is seeking supplier participation in a market engagement exercise for Pralidoxime Chloride supply in 2026 through a formal Request for Information process.
